Skip to main content

Cell & Gene Therapy News from CHOP

Cell & Gene Therapy News

The latest news from CHOP about cell and gene therapy.
News Brief

FDA Approves Two Gene Therapies for Sickle Cell Disease

The Food and Drug Administration (FDA) has approved CASGEVY™ (exagamglogene autotemcel) and LYFGENIA™ (lovotibeglogene autotemcel), the first two gene therapies for the treatment of sickle cell disease  in patients 12 years and older with recurrent vaso-occlusive crises (VOCs). 

Jump back to top